Co announces that it received 510(k) clearance from the FDA to market the BinaxNOW Malaria Test in the United States. The BinaxNOW test is the first and only rapid malaria test available in the US.
The move raises questions about the practical changes targeted companies may need to implement, given differing approaches between the United States and France. category US to revoke authorizations to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results